Carbonic anhydrase-9 expression levels and prognosis in human breast cancer: association with treatment outcome
Here, we set out to assess CA9 expression levels by real-time quantitative RT-PCR in breast cancer tissue samples obtained from 253 patients, and correlated those with relapse-free (RFS) survival. The median follow-up time was 75 months (range 2-168 months). CA9 expression was mainly found in high-g...
Saved in:
Published in | British journal of cancer Vol. 89; no. 2; pp. 271 - 276 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Basingstoke
Nature Publishing Group
21.07.2003
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Here, we set out to assess CA9 expression levels by real-time quantitative RT-PCR in breast cancer tissue samples obtained from 253 patients, and correlated those with relapse-free (RFS) survival. The median follow-up time was 75 months (range 2-168 months). CA9 expression was mainly found in high-grade, steroid receptor negative cancer tissues. CA9 levels were not significantly associated with RFS (P=0.926, hazard ratio (HR)=0.99, 95% CI=0.80-1.22) in the total cohort of 253 patients. In multivariate analysis with other clinicopathological factors, CA9 (P=0.018, HR=0.77, 95% CI=0.62-0.96), the interaction of adjuvant chemotherapy with CA9 (P=0.009, HR=1.31, 95% CI=1.07-1.61) and the interaction of adjuvant endocrine therapy with CA9 (P<0.001, HR=1.41, 95% CI=1.20-1.66) all contributed significantly to the final model. These results indicate that patients with low CA9 levels benefit more from adjuvant treatment than do patients with high levels. Thus, the determination of CA9 levels could aid in the selection of patients who will not benefit from adjuvant therapy, and whose prognosis will more likely improve with other treatment modalities. |
---|---|
AbstractList | Here, we set out to assess
CA9
expression levels by real-time quantitative RT–PCR in breast cancer tissue samples obtained from 253 patients, and correlated those with relapse-free (RFS) survival. The median follow-up time was 75 months (range 2–168 months).
CA9
expression was mainly found in high-grade, steroid receptor negative cancer tissues.
CA9
levels were not significantly associated with RFS (
P
=0.926, hazard ratio (HR)=0.99, 95% CI=0.80–1.22) in the total cohort of 253 patients. In multivariate analysis with other clinicopathological factors,
CA9
(
P
=0.018, HR=0.77, 95% CI=0.62–0.96), the interaction of adjuvant chemotherapy with
CA9
(
P
=0.009, HR=1.31, 95% CI=1.07–1.61) and the interaction of adjuvant endocrine therapy with
CA9
(
P
<0.001, HR=1.41, 95% CI=1.20–1.66) all contributed significantly to the final model. These results indicate that patients with low
CA9
levels benefit more from adjuvant treatment than do patients with high levels. Thus, the determination of
CA9
levels could aid in the selection of patients who will not benefit from adjuvant therapy, and whose prognosis will more likely improve with other treatment modalities. Here, we set out to assess CA9 expression levels by real-time quantitative RT-PCR in breast cancer tissue samples obtained from 253 patients, and correlated those with relapse-free (RFS) survival. The median follow-up time was 75 months (range 2-168 months). CA9 expression was mainly found in high-grade, steroid receptor negative cancer tissues. CA9 levels were not significantly associated with RFS (P=0.926, hazard ratio (HR)=0.99, 95% CI=0.80-1.22) in the total cohort of 253 patients. In multivariate analysis with other clinicopathological factors, CA9 (P=0.018, HR=0.77, 95% CI=0.62-0.96), the interaction of adjuvant chemotherapy with CA9 (P=0.009, HR=1.31, 95% CI=1.07-1.61) and the interaction of adjuvant endocrine therapy with CA9 (P<0.001, HR=1.41, 95% CI=1.20-1.66) all contributed significantly to the final model. These results indicate that patients with low CA9 levels benefit more from adjuvant treatment than do patients with high levels. Thus, the determination of CA9 levels could aid in the selection of patients who will not benefit from adjuvant therapy, and whose prognosis will more likely improve with other treatment modalities. |
Author | SPAN, P. N MANDERS, P BEEX, Lvam SWEEP, C. G. J BUSSINK, J |
Author_xml | – sequence: 1 givenname: P. N surname: SPAN fullname: SPAN, P. N organization: Department of Chemical Endocrinology, University Medical Centre Njmegen, Nijmegen, Netherlands – sequence: 2 givenname: J surname: BUSSINK fullname: BUSSINK, J organization: Department of Radiation Oncology, University Medical Centre Nijmegen, Njmegen, Netherlands – sequence: 3 givenname: P surname: MANDERS fullname: MANDERS, P organization: Department of Chemical Endocrinology, University Medical Centre Njmegen, Nijmegen, Netherlands – sequence: 4 givenname: Lvam surname: BEEX fullname: BEEX, Lvam organization: Department of Medical Oncology, University Medical Centre Nijmegen, Nijmegen, Netherlands – sequence: 5 givenname: C. G. J surname: SWEEP fullname: SWEEP, C. G. J organization: Department of Chemical Endocrinology, University Medical Centre Njmegen, Nijmegen, Netherlands |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15000588$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/12865916$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkc1v1DAQxS1URLeFKzeQhQS3LGMnTuIekNCKL6kSFzhbjuN0HSX24nEK_e_xakMLnKzR-83zG70LcuaDt4Q8Z7BlULZvcdx2o9nWNTDG-SOyYaLkBWt5c0Y2ANAUIDmckwvEMY8S2uYJOWe8rYVk9YaEnY5d8M5Q7fd3fdRoC0ntr0O0iC54OtlbO2FWe3qI4cYHdEidp_tl1p520WpM1GhvbLyiGjEYp9Nx8adLe5qynmbrEw1LMmG2T8njQU9on63vJfn-8cO33efi-uunL7v314WpapGKhutSA-8tGGk6Ias89txUPYiO1Y0WHdeDBV7LoZeWQVUJBtx0UpQMasbKS_Lu5HtYutn2JkeIelKH6GYd71TQTv2reLdXN-FW8VJWXJTZ4M1qEMOPxWJSs0Njp0l7GxZUTVmJuoQqg6_-A8ewRJ-Py14ATAA7um1PkIkBMdrhPgkDdSxS4ahykWotMi-8_Dv_A742l4HXK6DR6GmIuQKHD5zIbYu2zdyLE-d1WqK9B_589BvW77Sg |
CODEN | BJCAAI |
CitedBy_id | crossref_primary_10_2174_1574893617666220221120618 crossref_primary_10_2754_avb202392020143 crossref_primary_10_1016_j_ejmech_2021_114004 crossref_primary_10_1016_j_radonc_2013_04_022 crossref_primary_10_1186_1471_2407_14_400 crossref_primary_10_1021_acs_molpharmaceut_6b00502 crossref_primary_10_1016_j_bmc_2019_01_014 crossref_primary_10_1016_j_bmcl_2014_03_001 crossref_primary_10_1186_s13000_023_01325_9 crossref_primary_10_1371_journal_pone_0199476 crossref_primary_10_1158_1078_0432_CCR_11_0238 crossref_primary_10_1186_bcr3373 crossref_primary_10_1016_j_molonc_2008_03_006 crossref_primary_10_1002_ijc_22436 crossref_primary_10_1002_ijc_21106 crossref_primary_10_1016_j_bbamcr_2010_09_018 crossref_primary_10_1002_ardp_202200180 crossref_primary_10_1158_1078_0432_CCR_06_0480 crossref_primary_10_2967_jnumed_109_073189 crossref_primary_10_3389_fphar_2022_920747 crossref_primary_10_1002_ijc_23496 crossref_primary_10_1186_1471_2407_14_594 crossref_primary_10_1007_s10555_008_9144_9 crossref_primary_10_1016_S1389_1723_04_00265_8 crossref_primary_10_1186_gm271 crossref_primary_10_3390_ijms25031655 crossref_primary_10_1007_s00401_004_0938_8 crossref_primary_10_1259_bjr_82292521 crossref_primary_10_1038_s41598_021_00781_x crossref_primary_10_1016_j_acthis_2013_05_009 crossref_primary_10_1016_j_bbcan_2012_04_008 crossref_primary_10_1089_ars_2007_1623 crossref_primary_10_1111_his_12341 crossref_primary_10_3892_ijo_2016_3621 crossref_primary_10_1016_j_abb_2012_03_017 crossref_primary_10_1007_s00280_014_2635_1 crossref_primary_10_1016_j_advenzreg_2009_10_005 crossref_primary_10_1007_s00428_016_1953_6 crossref_primary_10_3892_ijo_2015_3253 crossref_primary_10_1021_acs_jmedchem_0c02077 crossref_primary_10_1053_j_semnuclmed_2014_10_002 crossref_primary_10_1093_bioinformatics_btt532 crossref_primary_10_1021_cr050262p crossref_primary_10_1016_j_drudis_2023_103761 crossref_primary_10_1038_sj_bjc_6604844 crossref_primary_10_1074_jbc_M110_188524 crossref_primary_10_1016_j_biosystems_2022_104790 crossref_primary_10_1007_s11060_009_9827_2 crossref_primary_10_1080_15384047_2018_1449612 crossref_primary_10_1038_sj_bjc_6603715 crossref_primary_10_1038_sj_bjc_6603716 crossref_primary_10_1016_j_taap_2019_114814 crossref_primary_10_1038_s41598_020_70396_1 crossref_primary_10_1097_PAI_0000000000001119 crossref_primary_10_3897_rrpharmacology_4_25251 crossref_primary_10_1016_j_freeradbiomed_2018_08_019 crossref_primary_10_1038_s41416_019_0461_2 crossref_primary_10_18632_oncotarget_24720 crossref_primary_10_3171_foc_2006_20_4_16 crossref_primary_10_1007_s00262_004_0650_5 crossref_primary_10_1007_s10585_007_9064_z crossref_primary_10_1016_j_athoracsur_2012_01_064 crossref_primary_10_1007_s12253_010_9355_6 crossref_primary_10_1016_j_bmcl_2014_05_021 crossref_primary_10_1016_j_yexcr_2012_12_010 crossref_primary_10_3171_2014_9_FOCUS14496 crossref_primary_10_1158_1078_0432_97_11_1 crossref_primary_10_1007_s00580_013_1712_x crossref_primary_10_1007_s12253_017_0284_5 crossref_primary_10_1111_joim_12091 crossref_primary_10_1371_journal_pone_0281396 crossref_primary_10_1111_iep_12213 crossref_primary_10_3390_diagnostics13213314 crossref_primary_10_1186_bcr2934 crossref_primary_10_1007_s00330_023_09572_6 crossref_primary_10_1016_j_cell_2020_07_003 crossref_primary_10_1038_bjc_2012_32 crossref_primary_10_1517_17530059_1_1_91 crossref_primary_10_1038_sj_bjc_6605090 |
Cites_doi | 10.1093/jnci/82.8.684 10.1200/JCO.2000.18.7.1423 10.1016/S0140-6736(98)03301-7 10.1006/geno.1996.0223 10.1023/A:1006141703224 10.1111/j.1349-7006.2001.tb01064.x 10.1093/jnci/93.17.1337 10.1016/S0140-6736(02)11402-4 10.1038/sj.bjc.6600215 10.1002/path.1120 10.1016/S0140-6736(97)11423-4 10.1046/j.1440-1827.2002.01335.x 10.1200/JCO.2001.19.16.3660 10.1023/A:1006193704132 10.1016/S1053-4296(96)80031-2 10.1023/A:1006197805041 10.1016/S0002-9440(10)65569-1 10.1080/095530000138259 10.1210/me.2001-0347 10.1016/S0002-9440(10)64048-5 10.1034/j.1399-3003.1999.14d14.x |
ContentType | Journal Article |
Copyright | 2003 INIST-CNRS Copyright Nature Publishing Group Jul 21, 2003 Copyright © 2003 Cancer Research UK 2003 Cancer Research UK |
Copyright_xml | – notice: 2003 INIST-CNRS – notice: Copyright Nature Publishing Group Jul 21, 2003 – notice: Copyright © 2003 Cancer Research UK 2003 Cancer Research UK |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7RV 7TO 7U9 7X7 7XB 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AN0 AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB0 LK8 M0S M1P M7P NAPCQ PQEST PQQKQ PQUKI 7X8 5PM |
DOI | 10.1038/sj.bjc.6601122 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) ProQuest Nursing and Allied Health Journals Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts ProQuest - Health & Medical Complete保健、医学与药学数据库 ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland British Nursing Database ProQuest Central Essentials Biological Science Collection AUTh Library subscriptions: ProQuest Central ProQuest Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection (Proquest) (PQ_SDU_P3) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Biological Science Database Nursing & Allied Health Premium ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Medical Library (Alumni) ProQuest Public Health Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition British Nursing Index with Full Text ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest Central Student MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | CA9 predicts breast cancer recurrence |
EISSN | 1532-1827 |
EndPage | 276 |
ExternalDocumentID | 984019291 10_1038_sj_bjc_6601122 12865916 15000588 6601122 |
Genre | Journal Article |
GeographicLocations | Netherlands |
GeographicLocations_xml | – name: Netherlands |
GroupedDBID | - -Q- 02 08R 0R 23N 39C 3V. 4.4 53G 55 5GY 5RE 7RV 7X7 88E 8AO 8C1 8FI 8FJ 8R4 8R5 AADWK AAPBV AAWBL AAWTL AAYJO AAZLF ABAWZ ABDBF ABDEU ABFLS ABGIJ ABOCM ABPTK ABUWG ACGFS ACKTT ACPRK ADACO ADBBV ADHDB ADQMX AEDAW AEJRE AENEX AFKRA AFRAH AFSHS AGEZK AHMBA AHSBF AJRNO ALFFA ALMA_UNASSIGNED_HOLDINGS AN0 ASPBG AVWKF AXYYD AZFZN B0M BAWUL BBAFP BBNVY BENPR BHPHI BKEYQ BKKNO BNQBC BPHCQ BVXVI CAG COF CS3 DIK DU5 E3Z EAD EAP EAS EBC EBD EBLON EBS EE. EIOEI EJD EMB EMK EPL ESX EX3 F5P FDQFY FEDTE FERAY FIZPM FRJ FSGXE FYUFA GX1 HCIFZ HVGLF HYE HZ IH2 J5H JSO KQ8 M1P M7P NAO NAPCQ O9- OK1 P2P PQEST PQQKQ PQUKI PRINS PROAC PSQYO Q- Q2X RIG RNT RNTTT RPM SNX SNYQT SV3 SWTZT TAOOD TBHMF TDRGL TR2 TUS UDS VH1 W2D WH7 WOW X7M XFK ZA5 ZGI --- .55 .GJ 0R~ 36B 406 6J9 70F 8WZ A6W AANZL AATNV AAUGY AAYFA ABLJU ACBMV ACBRV ACBYP ACGFO ACIGE ACRQY ACTTH ACVWB ADFRT ADMDM ADYYL AEFTE AEVLU AEXYK AFNRJ AGAYW AGGBP AGHAI AI. AILAN AJCLW AJDOV AMRJV AMYLF AOIJS CCPQU DNIVK DPUIP EMOBN HZ~ IQODW IWAJR JZLTJ M41 NQJWS NYICJ SOHCF SRMVM UKHRP Y6R ~02 ~8M AAYZH ABAKF ABZZP ACAOD ACZOJ AEFQL AEMSY AFBBN AGQEE CGR CUY CVF ECM EIF HMCUK NPM AAYXX CITATION 7TO 7U9 7XB 8FE 8FH 8FK AZQEC DWQXO GNUQQ H94 K9. LK8 7X8 5PM |
ID | FETCH-LOGICAL-c465t-72a3a02de0c9cb594a3ad2c4d05b167a5b2afe0269fd9e10445102cb953106113 |
IEDL.DBID | RPM |
ISSN | 0007-0920 |
IngestDate | Tue Sep 17 21:23:47 EDT 2024 Fri Aug 16 12:05:40 EDT 2024 Thu Oct 10 20:49:21 EDT 2024 Thu Sep 26 19:54:08 EDT 2024 Wed Oct 16 00:43:03 EDT 2024 Sun Oct 22 16:09:25 EDT 2023 Thu Oct 07 19:33:18 EDT 2021 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Human hypoxia Relapse Prognosis Enzyme Isozyme breast neoplasms quantitative real-time RT-PCR Lyases Malignant tumor Real time Polymerase chain reaction Mammary gland diseases survival analysis Carbonate dehydratase Mammary gland Molecular biology Carbon-oxygen lyases Hydro-lyases Quantitative analysis |
Language | English |
License | CC BY 4.0 This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c465t-72a3a02de0c9cb594a3ad2c4d05b167a5b2afe0269fd9e10445102cb953106113 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394253/ |
PMID | 12865916 |
PQID | 230015013 |
PQPubID | 41855 |
PageCount | 6 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2394253 proquest_miscellaneous_73456304 proquest_journals_230015013 crossref_primary_10_1038_sj_bjc_6601122 pubmed_primary_12865916 pascalfrancis_primary_15000588 nature_primary_6601122 |
ProviderPackageCode | ABDEU AEDAW AAZLF -Q- AADWK AAYJO ADQMX EE. RNTTT SWTZT ABGIJ RNT NAO |
PublicationCentury | 2000 |
PublicationDate | 2003-07-21 |
PublicationDateYYYYMMDD | 2003-07-21 |
PublicationDate_xml | – month: 07 year: 2003 text: 2003-07-21 day: 21 |
PublicationDecade | 2000 |
PublicationPlace | Basingstoke |
PublicationPlace_xml | – name: Basingstoke – name: England – name: London |
PublicationTitle | British journal of cancer |
PublicationTitleAlternate | Br J Cancer |
PublicationYear | 2003 |
Publisher | Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group |
References | Barratt, PL, Seymour, MT, Stenning, SP, Georgiades, I, Walker, C, Birbeck, K, Quirke, P 2002; 360 Bartosova, M, Parkkila, S, Pohlodek, K, Karttunen, TJ, Galbavy, S, Mucha, V, Harris, AL, Pastorek, J, Pastorekova, S 2002; 197 Hayes, DF, Trock, B, Harris, AL 1998; 52 Liao, SY, Aurelio, ON, Jan, K, Zavada, J, Stanbridge, EJ 1997; 57 Olive, PL, Aquino-Parsons, C, MacPhail, SH, Liao, SY, Raleigh, JA, Lerman, MI, Stanbridge, EJ 2001; 61 Lal, A, Peters, H, St Croix, B, Haroon, ZA, Dewhirst, MW, Strausberg, RL, Kaanders, JH, van der Kogel, AJ, Riggins, GJ 2001; 93 Giatromanolaki, A, Koukourakis, MI, Sivridis, E, Pastorek, J, Wykoff, CC, Gatter, KC, Harris, AL 2001; 61 Linderholm, B, Grankvist, K, Wilking, N, Johansson, M, Tavelin, B, Henriksson, R 2000; 18 Hui, EP, Chan, AT, Pezzella, F, Turley, H, To, KF, Poon, TC, Zee, B, Mo, F, Teo, PM, Huang, DP, Gatter, KC, Johnson, PJ, Harris, AL 2002; 8 Wykoff, CC, Beasley, NJ, Watson, PH, Turner, KJ, Pastorek, J, Sibtain, A, Wilson, GD, Turley, H, Talks, KL, Maxwell, PH, Pugh, CW, Ratcliffe, PJ, Harris, AL 2000; 60 1998; 352 Rofstad, EK 2000; 76 Gasparini, G, Toi, M, Miceli, R, Vermeulen, PB, Dittadi, R, Biganzoli, E, Morabito, A, Fanelli, M, Gatti, C, Suzuki, H, Tominaga, T, Dirix, LY, Gion, M 1999; 5 Loncaster, JA, Harris, AL, Davidson, SE, Logue, JP, Hunter, RD, Wycoff, CC, Pastorek, J, Ratcliffe, PJ, Stratford, IJ, West, CM 2001; 61 Stoner, M, Saville, B, Wormke, M, Dean, D, Burghardt, R, Safe, S 2002; 16 Kurebayashi, J, Otsuki, T, Moriya, T, Sonoo, H 2001; 92 Luk, CK, Veinot-Drebot, L, Tjan, E, Tannock, IF 1990; 82 Vermylen, P, Roufosse, C, Burny, A, Verhest, A, Bosschaerts, T, Pastorekova, S, Ninane, V, Sculier, JP 1999; 14 Harbeck, N, Kates, RE, Look, MP, Meijer-Van Gelder, ME, Klijn, JG, Kruger, A, Kiechle, M, Janicke, F, Schmitt, M, Foekens, JA 2002; 62 Koukourakis, MI, Giatromanolaki, A, Sivridis, E, Simopoulos, K, Pastorek, J, Wykoff, CC, Gatter, KC, Harris, AL 2001; 7 Turner, KJ, Crew, JP, Wykoff, CC, Watson, PH, Poulsom, R, Pastorek, J, Ratcliffe, PJ, Cranston, D, Harris, AL 2002; 86 Höckel, M, Schlenger, K, Mitze, M, Schaffer, U, Vaupel, P 1996b; 6 Henderson, IC, Patek, AJ 1998; 52 Opavsky, R, Pastorekova, S, Zelnik, V, Gibadulinova, A, Stanbridge, EJ, Zavada, J, Kettmann, R, Pastorek, J 1996; 33 1996; 351 Höckel, M, Schlenger, K, Aral, B, Mitze, M, Schaffer, U, Vaupel, P 1996a; 56 Mori, I, Yang, Q, Kakudo, K 2002; 52 Saarnio, J, Parkkila, S, Parkkila, AK, Haukipuro, K, Pastorekova, S, Pastorek, J, Kairaluoma, MI, Karttunen, TJ 1998; 153 Altman, DG, Lyman, GH 1998; 52 Wykoff, CC, Beasley, N, Watson, PH, Campo, L, Chia, SK, English, R, Pastorek, J, Sly, WS, Ratcliffe, P, Harris, AL 2001; 158 Foekens, JA, Ries, C, Look, MP, Gippner-Steppert, C, Klijn, JG, Jochum, M 2003; 63 Chia, SK, Wykoff, CC, Watson, PH, Han, C, Leek, RD, Pastorek, J, Gatter, KC, Ratcliffe, P, Harris, AL 2001; 19 DG Altman (BF6601122_CR1) 1998; 52 IC Henderson (BF6601122_CR12) 1998; 52 JA Foekens (BF6601122_CR7) 2003; 63 PL Olive (BF6601122_CR24) 2001; 61 CC Wykoff (BF6601122_CR32) 2000; 60 M Höckel (BF6601122_CR13) 1996; 56 B Linderholm (BF6601122_CR20) 2000; 18 R Opavsky (BF6601122_CR25) 1996; 33 MI Koukourakis (BF6601122_CR16) 2001; 7 M Stoner (BF6601122_CR28) 2002; 16 SK Chia (BF6601122_CR4) 2001; 19 I Mori (BF6601122_CR23) 2002; 52 M Höckel (BF6601122_CR14) 1996; 6 A Lal (BF6601122_CR18) 2001; 93 BF6601122_CR6 PL Barratt (BF6601122_CR2) 2002; 360 CC Wykoff (BF6601122_CR31) 2001; 158 N Harbeck (BF6601122_CR10) 2002; 62 G Gasparini (BF6601122_CR8) 1999; 5 A Giatromanolaki (BF6601122_CR9) 2001; 61 BF6601122_CR5 EK Rofstad (BF6601122_CR26) 2000; 76 M Bartosova (BF6601122_CR3) 2002; 197 SY Liao (BF6601122_CR19) 1997; 57 KJ Turner (BF6601122_CR29) 2002; 86 J Saarnio (BF6601122_CR27) 1998; 153 J Kurebayashi (BF6601122_CR17) 2001; 92 CK Luk (BF6601122_CR22) 1990; 82 DF Hayes (BF6601122_CR11) 1998; 52 P Vermylen (BF6601122_CR30) 1999; 14 EP Hui (BF6601122_CR15) 2002; 8 JA Loncaster (BF6601122_CR21) 2001; 61 |
References_xml | – volume: 153 start-page: 279 year: 1998 end-page: 285 article-title: Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN CA IX, with potential value as a marker of cell proliferation publication-title: Am J Pathol contributor: fullname: Karttunen, TJ – volume: 52 start-page: 186 year: 2002 end-page: 194 article-title: Predictive and prognostic markers for invasive breast cancer publication-title: Pathol Int contributor: fullname: Kakudo, K – volume: 92 start-page: 1093 year: 2001 end-page: 1101 article-title: Hypoxia reduces hormone responsiveness of human breast cancer cells publication-title: Jpn J Cancer Res contributor: fullname: Sonoo, H – volume: 76 start-page: 589 year: 2000 end-page: 605 article-title: Microenvironment-induced cancer metastasis publication-title: Int J Radial Biol contributor: fullname: Rofstad, EK – volume: 56 start-page: 4509 year: 1996a end-page: 4515 article-title: Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix publication-title: Cancer Res contributor: fullname: Vaupel, P – volume: 360 start-page: 1381 year: 2002 end-page: 1391 article-title: DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study publication-title: Lancet contributor: fullname: Quirke, P – volume: 61 start-page: 7992 year: 2001 end-page: 7998 article-title: Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer publication-title: Cancer Res contributor: fullname: Harris, AL – volume: 61 start-page: 6394 year: 2001 end-page: 6399 article-title: Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix publication-title: Cancer Res contributor: fullname: West, CM – volume: 18 start-page: 1423 year: 2000 end-page: 1431 article-title: Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment publication-title: J Clin Oncol contributor: fullname: Henriksson, R – volume: 158 start-page: 1011 year: 2001 end-page: 1019 article-title: Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma of the breast publication-title: Am J Pathol contributor: fullname: Harris, AL – volume: 57 start-page: 2827 year: 1997 end-page: 2831 article-title: Identification of the MN CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney publication-title: Cancer Res contributor: fullname: Stanbridge, EJ – volume: 52 start-page: 289 year: 1998 end-page: 303 article-title: Methodological challenges in the evaluation of prognostic factors in breast cancer publication-title: Breast Cancer Res Treat contributor: fullname: Lyman, GH – volume: 197 start-page: 314 year: 2002 end-page: 321 article-title: Expression of carbonic anhydrase IX in breast is associated with malignant tissues and is related to overexpression of c-erbB2 publication-title: J Pathol contributor: fullname: Pastorekova, S – volume: 63 start-page: 337 year: 2003 end-page: 341 article-title: The prognostic value of polymorphonuclear leukocyte elastase in patients with primary breast cancer publication-title: Cancer Res contributor: fullname: Jochum, M – volume: 8 start-page: 2595 year: 2002 end-page: 2604 article-title: Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival publication-title: Clin Cancer Res contributor: fullname: Harris, AL – volume: 351 start-page: 1451 year: 1996 end-page: 1467 article-title: Tamoxifen for early breast cancer: an overview of the randomised trials publication-title: Lancet – volume: 52 start-page: 261 year: 1998 end-page: 288 article-title: The relationship between prognostic and predictive factors in the management of breast cancer publication-title: Breast Cancer Res Treat contributor: fullname: Patek, AJ – volume: 7 start-page: 3399 year: 2001 end-page: 33403 article-title: Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy publication-title: Clin Cancer Res contributor: fullname: Harris, AL – volume: 61 start-page: 8924 year: 2001 end-page: 8929 article-title: Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer publication-title: Cancer Res contributor: fullname: Stanbridge, EJ – volume: 5 start-page: 101 year: 1999 end-page: 111 article-title: Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy publication-title: Cancer J Sci Am contributor: fullname: Gion, M – volume: 52 start-page: 305 year: 1998 end-page: 319 article-title: Assessing the clinical impact of prognostic factors: when is "statistically significant" clinically useful? publication-title: Breast Cancer Res Treat contributor: fullname: Harris, AL – volume: 352 start-page: 930 year: 1998 end-page: 942 article-title: Poly-chemotherapy for early breast cancer: an overview of the randomised trials publication-title: Lancet – volume: 14 start-page: 806 year: 1999 end-page: 811 article-title: Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma publication-title: Eur Respir J contributor: fullname: Sculier, JP – volume: 62 start-page: 4617 year: 2002 end-page: 4622 article-title: Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 ( =3424) publication-title: Cancer Res contributor: fullname: Foekens, JA – volume: 6 start-page: 3 year: 1996b end-page: 9 article-title: Hypoxia and radiation response in human tumors publication-title: Semin Radiat Oncol contributor: fullname: Vaupel, P – volume: 60 start-page: 7075 year: 2000 end-page: 7083 article-title: Hypoxia-inducible expression of tumor-associated carbonic anhydrases publication-title: Cancer Res contributor: fullname: Harris, AL – volume: 86 start-page: 1276 year: 2002 end-page: 1282 article-title: The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial invasive bladder cancer publication-title: Br J Cancer contributor: fullname: Harris, AL – volume: 33 start-page: 480 year: 1996 end-page: 487 article-title: Human MN CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships publication-title: Genomics contributor: fullname: Pastorek, J – volume: 82 start-page: 684 year: 1990 end-page: 692 article-title: Effect of transient hypoxia on sensitivity to doxorubicin in human and murine cell lines publication-title: J Natl Cancer Inst contributor: fullname: Tannock, IF – volume: 19 start-page: 3660 year: 2001 end-page: 3668 article-title: Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma publication-title: J Clin Oncol contributor: fullname: Harris, AL – volume: 93 start-page: 1337 year: 2001 end-page: 1343 article-title: Transcriptional response to hypoxia in human tumors publication-title: J Natl Cancer Inst contributor: fullname: Riggins, GJ – volume: 16 start-page: 2231 year: 2002 end-page: 2242 article-title: Hypoxia induces proteasome-dependent degradation of estrogen receptor alpha in ZR-75 breast cancer cells publication-title: Mol Endocrinol contributor: fullname: Safe, S – volume: 61 start-page: 7992 year: 2001 ident: BF6601122_CR9 publication-title: Cancer Res contributor: fullname: A Giatromanolaki – volume: 60 start-page: 7075 year: 2000 ident: BF6601122_CR32 publication-title: Cancer Res contributor: fullname: CC Wykoff – volume: 82 start-page: 684 year: 1990 ident: BF6601122_CR22 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/82.8.684 contributor: fullname: CK Luk – volume: 18 start-page: 1423 year: 2000 ident: BF6601122_CR20 publication-title: J Clin Oncol doi: 10.1200/JCO.2000.18.7.1423 contributor: fullname: B Linderholm – ident: BF6601122_CR6 doi: 10.1016/S0140-6736(98)03301-7 – volume: 62 start-page: 4617 year: 2002 ident: BF6601122_CR10 publication-title: Cancer Res contributor: fullname: N Harbeck – volume: 33 start-page: 480 year: 1996 ident: BF6601122_CR25 publication-title: Genomics doi: 10.1006/geno.1996.0223 contributor: fullname: R Opavsky – volume: 52 start-page: 261 year: 1998 ident: BF6601122_CR12 publication-title: Breast Cancer Res Treat doi: 10.1023/A:1006141703224 contributor: fullname: IC Henderson – volume: 57 start-page: 2827 year: 1997 ident: BF6601122_CR19 publication-title: Cancer Res contributor: fullname: SY Liao – volume: 7 start-page: 3399 year: 2001 ident: BF6601122_CR16 publication-title: Clin Cancer Res contributor: fullname: MI Koukourakis – volume: 92 start-page: 1093 year: 2001 ident: BF6601122_CR17 publication-title: Jpn J Cancer Res doi: 10.1111/j.1349-7006.2001.tb01064.x contributor: fullname: J Kurebayashi – volume: 93 start-page: 1337 year: 2001 ident: BF6601122_CR18 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/93.17.1337 contributor: fullname: A Lal – volume: 360 start-page: 1381 year: 2002 ident: BF6601122_CR2 publication-title: Lancet doi: 10.1016/S0140-6736(02)11402-4 contributor: fullname: PL Barratt – volume: 86 start-page: 1276 year: 2002 ident: BF6601122_CR29 publication-title: Br J Cancer doi: 10.1038/sj.bjc.6600215 contributor: fullname: KJ Turner – volume: 197 start-page: 314 year: 2002 ident: BF6601122_CR3 publication-title: J Pathol doi: 10.1002/path.1120 contributor: fullname: M Bartosova – ident: BF6601122_CR5 doi: 10.1016/S0140-6736(97)11423-4 – volume: 52 start-page: 186 year: 2002 ident: BF6601122_CR23 publication-title: Pathol Int doi: 10.1046/j.1440-1827.2002.01335.x contributor: fullname: I Mori – volume: 19 start-page: 3660 year: 2001 ident: BF6601122_CR4 publication-title: J Clin Oncol doi: 10.1200/JCO.2001.19.16.3660 contributor: fullname: SK Chia – volume: 52 start-page: 289 year: 1998 ident: BF6601122_CR1 publication-title: Breast Cancer Res Treat doi: 10.1023/A:1006193704132 contributor: fullname: DG Altman – volume: 56 start-page: 4509 year: 1996 ident: BF6601122_CR13 publication-title: Cancer Res contributor: fullname: M Höckel – volume: 8 start-page: 2595 year: 2002 ident: BF6601122_CR15 publication-title: Clin Cancer Res contributor: fullname: EP Hui – volume: 6 start-page: 3 year: 1996 ident: BF6601122_CR14 publication-title: Semin Radiat Oncol doi: 10.1016/S1053-4296(96)80031-2 contributor: fullname: M Höckel – volume: 52 start-page: 305 year: 1998 ident: BF6601122_CR11 publication-title: Breast Cancer Res Treat doi: 10.1023/A:1006197805041 contributor: fullname: DF Hayes – volume: 153 start-page: 279 year: 1998 ident: BF6601122_CR27 publication-title: Am J Pathol doi: 10.1016/S0002-9440(10)65569-1 contributor: fullname: J Saarnio – volume: 76 start-page: 589 year: 2000 ident: BF6601122_CR26 publication-title: Int J Radial Biol doi: 10.1080/095530000138259 contributor: fullname: EK Rofstad – volume: 63 start-page: 337 year: 2003 ident: BF6601122_CR7 publication-title: Cancer Res contributor: fullname: JA Foekens – volume: 61 start-page: 6394 year: 2001 ident: BF6601122_CR21 publication-title: Cancer Res contributor: fullname: JA Loncaster – volume: 61 start-page: 8924 year: 2001 ident: BF6601122_CR24 publication-title: Cancer Res contributor: fullname: PL Olive – volume: 16 start-page: 2231 year: 2002 ident: BF6601122_CR28 publication-title: Mol Endocrinol doi: 10.1210/me.2001-0347 contributor: fullname: M Stoner – volume: 158 start-page: 1011 year: 2001 ident: BF6601122_CR31 publication-title: Am J Pathol doi: 10.1016/S0002-9440(10)64048-5 contributor: fullname: CC Wykoff – volume: 5 start-page: 101 year: 1999 ident: BF6601122_CR8 publication-title: Cancer J Sci Am contributor: fullname: G Gasparini – volume: 14 start-page: 806 year: 1999 ident: BF6601122_CR30 publication-title: Eur Respir J doi: 10.1034/j.1399-3003.1999.14d14.x contributor: fullname: P Vermylen |
SSID | ssj0009087 |
Score | 2.1410449 |
Snippet | Here, we set out to assess CA9 expression levels by real-time quantitative RT-PCR in breast cancer tissue samples obtained from 253 patients, and correlated... Here, we set out to assess CA9 expression levels by real-time quantitative RT–PCR in breast cancer tissue samples obtained from 253 patients, and correlated... |
SourceID | pubmedcentral proquest crossref pubmed pascalfrancis nature |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 271 |
SubjectTerms | Antigens, Neoplasm - analysis Antineoplastic Agents, Hormonal - pharmacology Biological and medical sciences Biomarkers, Tumor - analysis Breast cancer Breast Neoplasms - pathology Breast Neoplasms - therapy Cancer research Cancer therapies Carbonic Anhydrase IX Carbonic Anhydrases - analysis Chemotherapy Chemotherapy, Adjuvant Clinical outcomes Disease-Free Survival DNA, Neoplasm Drug Resistance, Neoplasm Endocrine therapy Endocrinology Female Follow-Up Studies Gene Expression Regulation, Neoplastic Gynecology. Andrology. Obstetrics Humans Hypoxia Immunohistochemistry Isoenzymes Mammary gland diseases Mastectomy, Modified Radical Medical prognosis Medical research Medical sciences Metastasis Molecular and Cellular Pathology Neoplasm Proteins - analysis Oncology Predictive Value of Tests Prognosis Radiotherapy, Adjuvant Receptors, Steroid - analysis Reverse Transcriptase Polymerase Chain Reaction Surgery Survival Analysis Tumors |
SummonAdditionalLinks | – databaseName: AUTh Library subscriptions: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fi9QwEA56ByKI-Ou0np55EHzKXTtN2sYX0eOOQ7hDxIN7K2ma5XaRdN10Qf97Z9ps1xXxsUwJJTOTmcl8_Yaxt8a1SmMoE9raUsjcVMKAs6IAp5QrQMsBVXl5VVxcy8836iZic0KEVW7OxOGgbjtLd-QnmCpTcZ7lH5Y_BA2NouZqnKBxl-1DJqlLu__p7OrL1y3rblqNpJl0H6ch3bA25tVJWBw3C3tcYEGSAexEpYlT88HSBNyp2Tji4l856N9Qyj9i0_kj9jAmlfzjaAWP2R3nn7B7l7Ft_pR1p2bVEAcuN_72V7vCyCU0dz8jCNbz7wQdCihtOQG2fBfmgc89Hyb48YaA6z23ZCCr99xsNcrpGpdPYHXerXvcTfeMXZ-ffTu9EHHSgrCyUL0oweQmhdalVttGaYmPLVjZpqrJitKoBszMYbmmZ612WMFJdGWwjUYPxoQgyw_Ynu-8e8G4NqABSodlIiYnRDbvDOCGm1YX2kiTsHebna6XI6FGPTTC86oOixp1UkedJOxgVMT03iQ42lHMdh2a7qCqKmGHG03V0SVDPRlQwt5MUvQlapAY77p1qMtcEl2aTNjzUavblekHXsykE1bu6Ht6gVi6dyV-fjuwddPseVD5y_9-0yG7P6AE0U4he8X2-tXavcZsp2-Ook3_BhYOAJ4 priority: 102 providerName: ProQuest |
Title | Carbonic anhydrase-9 expression levels and prognosis in human breast cancer: association with treatment outcome |
URI | http://dx.doi.org/10.1038/sj.bjc.6601122 https://www.ncbi.nlm.nih.gov/pubmed/12865916 https://www.proquest.com/docview/230015013 https://search.proquest.com/docview/73456304 https://pubmed.ncbi.nlm.nih.gov/PMC2394253 |
Volume | 89 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swED_aDsZgjO6jm9c108NgT05sfdjW3rbQUgYpZayQNyPJCk1o5RA7sP33O_krzehTXwzmZGF0d9yd9NPvAL4oWwiJoSyUxqQhZyoLFbUmTKgVwiZU8gZVObtKLm_4z7mYH4Do78I0oH2jl2N3dz92y9sGW7m-N5MeJza5nk19O28q2OQQDlPG-hK9Z9qNspYo0-_BSRr1TI0sm1SrsV6ZcYJFSEybPjb-Xqb0vc4fBKWBUvPlWlW4UIu2w8VjKej_SMoHoeniGF51OSX53v77aziw7g08n3Wn5m-hnKqN9hS4RLnbv8UGA1coif3TYWAdufPIoQqlBfF4LVdWy4osHWka-BHtces1Md4-Nt-I2imU-F1cMmDVSbmt0YDtO7i5OP89vQy7Rguh4Ymow5QqpiJa2MhIo4Xk-FpQw4tI6DhJldBULSxWa3JRSIsFHEdPpkZLdGDMB2J2AkeudPYDEKmopDS1WCVibuK55q2iuPaqkIlUXAXwtV_pfN3yaeTNOTjL8mqVo3ryTj0BnLSKGMYNgtGeYnbz-OYOIssCOO01lXceWeVYavnNnZgF8HmQoiv58xHlbLmt8pRxz5bGA3jfanU3c2cnAaR7-h4GeJLufQnabkPW3dnqxyd_eQovGgAhmjONP8FRvdnaM0yEaj1C85-n-Mym8Qie_Ti_uv41apzhH95XDBc |
link.rule.ids | 230,315,733,786,790,891,12083,12250,21416,27955,27956,31752,31753,33299,33300,33777,33778,43343,43612,43838,53825,53827,74100,74369,74657 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fi9QwEB70BBVE_HVaT-_yIPiUuzZN2sYXkcVj1dt7uoN7K2ma5XaRdN10Qf97Z9pu1xXxsSSEMjPJzGS-fAPwzrhaaXRlXFubc5maghvhLM-EU8plQssOVTm7zKbX8uuNuhmwOWGAVW7PxO6grhtLd-RnGCpTcp6kH1c_ODWNouLq0EHjLtyTKbpqeig-2SE8dFz0lJl0G6dFvOVsTIuzsDytlvY0w3QkEWLPJ42Mmo9WJqCc5n2Di39FoH8DKf_wTOdP4PEQUrJPvQ08hTvOP4P7s6Fo_hyaiVlXxIDLjL_9Va_Rb3HN3M8BAuvZdwIOBRytGcG1fBMWgS086_r3sYpg6y2zZB7rD8zs9MnoEpeNUHXWbFqUpXsB1-efryZTPvRZ4FZmquW5MKmJRe1iq22ltMTPWlhZx6pKstyoSpi5w2RNz2vtMH-TuJGFrTTuXwwHkvQQDnzj3Stg2ggtRO4wScTQhKjmnREocFPrTBtpIni_lXS56uk0yq4MnhZlWJaok3LQSQSHvSLGeePA8Z5idutQbwdVFBEcbTVVDhsylKP5RHAyjuJOovKI8a7ZhDJPJZGlyQhe9lrdrUzPdzGOjiDf0_c4gTi690f84rbj6qbO80Klr__7TyfwYHo1uygvvlx-O4KHHV4QbVYkb-CgXW_cW4x72uq4s-7fpacB8A |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swED-2FspglH21c7u1ehjsSY0tS7a1l7F1Dd1HQxkr9M3IkkIThp1FDmz__U624ixj7NGcEeY-dHfSz78DeKWsERJTGZVa55SnqqCKWU0zZoWwGZO8Q1VeTbLLG_7pVtwGSiEXYJXrPbHbqE2j_Rn5CEtl35wn6WgaUBHXH8ZvFz-oHyDlL1rDNI37sJvzTGAftvv-YnL9dcPAGxc9gaY_m5MsXjM4psXIzc-quT7LsDlJGNvKUAO_5sOFcqi1aT_u4l_16N-wyj_y1PgR7IcCk7zrPeIx3LP1E9i7ClfoT6E5V8vK8-ESVd_9MkvMYlQS-zMAYmvy3cOIHEoN8eCtunEzR2Y16ab5kcqD2FuivbMs3xC1sS7xR7pkAK6TZtWiZu0zuBlffDu_pGHqAtWot5bmTKUqZsbGWupKSI6PhmluYlElWa5ExdTUYusmp0Za7OY4hjXTlcRoxuIgSQ9gp25q-xyIVEwylltsGbFQ8cTzVjFUuDIyk4qrCF6vNV0uenKNsrsUT4vSzUu0SRlsEsFBb4jhvUFwsmWYzTp-0oMoigiO15YqQ3i6cnCmCE4HKcaVvyxRtW1WrsxT7qnTeASHvVU3K_ufebGqjiDfsvfwgmfs3pbUs7uOudvPoWciPfrvN53CHrp2-eXj5PMxPOjAg-iyLHkBO-1yZV9iEdRWJ8G9fwN0OQfI |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Carbonic+anhydrase-9+expression+levels+and+prognosis+in+human+breast+cancer%3A+association+with+treatment+outcome&rft.jtitle=British+journal+of+cancer&rft.au=SPAN%2C+P.+N&rft.au=BUSSINK%2C+J&rft.au=MANDERS%2C+P&rft.au=BEEX%2C+Lvam&rft.date=2003-07-21&rft.pub=Nature+Publishing+Group&rft.issn=0007-0920&rft.eissn=1532-1827&rft.volume=89&rft.issue=2&rft.spage=271&rft.epage=276&rft_id=info:doi/10.1038%2Fsj.bjc.6601122&rft.externalDBID=n%2Fa&rft.externalDocID=15000588 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-0920&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-0920&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-0920&client=summon |